|
|
|
|
|
|
By Nathalie Huther, Ph.D., MBA; Carlos N Velez, Ph.D., MBA | In Part 1, we introduced the critical link between CMC and prospective investors and/or licensees. Here we conclude with suggestions for how CDMOs can lend expertise early in discovery/development to improve the probability of securing investment or license for their clients. | |
|
|
|
|
| 3 Keys To Success When Planning With Your CMO Partner | Article | Argonaut Manufacturing Services | Once you've identified a CMO partner, how do you ensure success? The secret: planning as early as possible – while your product is still in preclinical or clinical development. |
|
|
|
|
|
|
|
| Webinar: Fixing the Fixed: Unlocking Efficiency in Large-Scale Microbial Manufacturing | Commercial biomanufacturing isn't static—it's an evolving process. This webinar shares real-world case studies from Lonza’s microbial manufacturing facility, highlighting how continuous improvement is achieved through data-driven yield optimization, process refinement, and deviation analysis. Attendees will learn how to maintain agility, apply Six Sigma tools, and build resilience into operations to enhance efficiency, quality, and performance. Click here to learn more. |
|
|
|
|
|
|
|
|
|
|
Connect With Bioprocess Online: |
|
|
|